#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4012794	Functional	Antiviral activity against Human rhinovirus B14 infected in H1HeLa cells assessed as decrease in viral dsRNA at 6 times EC50 treated every 1 hr for 9 hrs after infection by DAPI staining based immunofluorescence assay	rhinovirus B14	2	ALA4011621	cell-based format	Scientific Literature
2.	ALA4012795	Functional	Antiviral activity against Human rhinovirus B14 infected in human H1HeLa cells assessed as protection against virus induced cytopathic effect after 3 days by MTT assay	rhinovirus B14	43	ALA4011621	cell-based format	Scientific Literature
3.	ALA4012796	Functional	Antiviral activity against Human rhinovirus A21 infected in human H1HeLa cells assessed as protection against virus induced cytopathic effect after 3 days by MTT assay	rhinovirus A21	41	ALA4011621	cell-based format	Scientific Literature
4.	ALA4012797	ADME	Cytotoxicity against human H1HeLa cells assessed as decrease in cell viability after 3 days by MTT assay	Homo sapiens	41	ALA4011621	cell-based format	Scientific Literature
5.	ALA4012798	Functional	Antiviral activity against Human rhinovirus A71 infected in human H1HeLa cells assessed as protection against virus induced cytopathic effect after 3 days by MTT assay	Human rhinovirus A71	41	ALA4011621	cell-based format	Scientific Literature
6.	ALA4012799	Toxicity	Selectivity index, ratio of CC50 for human H1HeLa cells to EC50 for Human rhinovirus B14 infected in human H1HeLa cells		21	ALA4011621	cell-based format	Scientific Literature
7.	ALA4012800	Toxicity	Selectivity index, ratio of CC50 for human H1HeLa cells to EC50 for Human rhinovirus A21 infected in human H1HeLa cells		30	ALA4011621	cell-based format	Scientific Literature
8.	ALA4012801	Toxicity	Selectivity index, ratio of CC50 for human H1HeLa cells to EC50 for Human rhinovirus A71 infected in human H1HeLa cells		36	ALA4011621	cell-based format	Scientific Literature
9.	ALA4012802	Functional	Antiviral activity against Human poliovirus 3 infected in human HeLa cells assessed as protection against virus induced cytopathic effect after 2 days by MTT assay	Poliovirus 3	41	ALA4011621	cell-based format	Scientific Literature
10.	ALA4012803	ADME	Cytotoxicity aganist human HeLa cells assessed as decrease in cell viability after 2 days by MTT assay	Homo sapiens	41	ALA4011621	cell-based format	Scientific Literature
11.	ALA4012804	Toxicity	Selectivity index, ratio of CC50 for human HeLa cells to EC50 for human poliovirus 3 infected in human HeLa cells		27	ALA4011621	cell-based format	Scientific Literature
12.	ALA4012805	Functional	Antiviral activity against Human rhinovirus A16 infected in human H1HeLa cells assessed as protection against virus induced cytopathic effect after 3 days by MTT assay	rhinovirus A16	3	ALA4011621	cell-based format	Scientific Literature
13.	ALA4012806	Functional	Antiviral activity against Human rhinovirus B14 infected in H1HeLa cells assessed as decrease in viral dsRNA at 6 times EC50 treated 1 hr prior to infection by DAPI staining based immunofluorescence assay	rhinovirus B14	2	ALA4011621	cell-based format	Scientific Literature
14.	ALA4012807	Functional	Antiviral activity against Human rhinovirus B14 infected in H1HeLa cells assessed as decrease in viral dsRNA at 6 times EC50 treated simultaneously with infection by DAPI staining based immunofluorescence assay	rhinovirus B14	2	ALA4011621	cell-based format	Scientific Literature
15.	ALA4012809	Functional	Antiviral activity against Human rhinovirus A16 infected in H1HeLa cells assessed as decrease in viral dsRNA at 6 times EC50 treated 1 hr prior to infection by DAPI staining based immunofluorescence assay	rhinovirus A16	2	ALA4011621	cell-based format	Scientific Literature
16.	ALA4012810	Functional	Antiviral activity against Human rhinovirus A16 infected in H1HeLa cells assessed as decrease in viral dsRNA at 6 times EC50 treated simultaneously with infection by DAPI staining based immunofluorescence assay	rhinovirus A16	2	ALA4011621	cell-based format	Scientific Literature
17.	ALA4012811	Functional	Antiviral activity against Human rhinovirus A16 infected in H1HeLa cells assessed as decrease in viral dsRNA at 6 times EC50 treated every 1 hr for 9 hrs after infection by DAPI staining based immunofluorescence assay	rhinovirus A16	1	ALA4011621	cell-based format	Scientific Literature
18.	ALA4012812	Functional	Antiviral activity against Human rhinovirus B14 harboring VP1 A150V/E276K double mutant infected in human HeLa Rh cells assessed as protection against virus induced cytopathic effect after 3 days by MTT assay	rhinovirus B14	4	ALA4011621	cell-based format	Scientific Literature
19.	ALA4012813	Functional	Antiviral activity against Human rhinovirus B14 harboring VP1 C199Y mutant infected in human HeLa Rh cells assessed as protection against virus induced cytopathic effect after 3 days by MTT assay	rhinovirus B14	4	ALA4011621	cell-based format	Scientific Literature
20.	ALA4012814	Functional	Resistance index, ratio of EC50 for Human rhinovirus B14 harboring VP1 A150V/E276K double mutant infected in human HeLa Rh cells to EC50 for Human rhinovirus B14 infected in human H1HeLa cells	rhinovirus B14	4	ALA4011621	cell-based format	Scientific Literature